ישראל - עברית - Ministry of Health

sanofi israel ltd - clofarabine - תרכיז להכנת תמיסה לאינפוזיה - clofarabine 1 mg/ml - clofarabine - clofarabine - treatment of acute lymphoblastic leukaemia (all) in paediatric patients who have relapsed or are refractory after receiving at least two prior regimens and who are about to undergo transplantation. safety and efficacy have been assessed in studies of patients < or = 21 years old at initial diagnosis .

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - clofarabine - תרכיז להכנת תמיסה לאינפוזיה - clofarabine 1 mg / 1 ml - clofarabine

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - clofarabine 1 mg/ml - concentrate for solution for infusion - clofarabine - treatment of acute lymphoblastic leukaemia (all) in paediatric patients who have relapsed or are refractory after receiving at least two prior regimens and who are about to undergo transplantation. safety and efficacy have been assessed in studies of patients < or = 21 years old at initial diagnosis .

ישראל - עברית - Ministry of Health

novartis israel ltd - fludarabine phosphate - תרכיז להכנת תמיסה לאינפוזיה\הזרקה - fludarabine phosphate 50 mg/dose - fludarabine - fludarabine - palliative treatment of patients with cll refractory to other therapy. treatment of less malignant non-hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. fludarabine is indicated for the initial treatment of patients with b- cell chronic lymphocytic leukaemia (cll) or after first line therapy, in patients with sufficient bone marrow reserves.

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - clomipramine hydrochloride - טבליות בשחרור איטי - clomipramine hydrochloride 75 mg - clomipramine - clomipramine - depression of varying origin: in children and adolescents there is not sufficient evidence of safety and efficacy of anafranil in the treatment of depressive states of varying aetiology and symptomatology. the use of anafranil in children and odolescents ( 0 - 17 years of age ) in this indication is therefore not recommended. obsessive compulcive syndromes: no experience is available in children younger than 5 years of age.

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - clomipramine hydrochloride - טבליות מצופות - clomipramine hydrochloride 25 mg - clomipramine - clomipramine - depression of varying origin: in children and adolescents there is not sufficient evidence of safety and efficacy of anafranil in the treatment of depressive states of varying aetiology and symptomatology. the use of anafranil in children and odolescents ( 0 - 17 years of age ) in this indication is therefore not recommended. obsessive compulcive syndromes: no experience is available in children younger than 5 years of age.

ישראל - עברית - Ministry of Health

propharm ltd - cladribine - תמיסה להזרקה\אינפוזיה - cladribine 10 mg / 5 ml - cladribine - cladribine - hairy cell leukemia. chronic lymphocytic leukemia. second line treatment for low grade non-hodgkin's lymphoma.

ישראל - עברית - Ministry of Health

unipharm ltd, israel - clomipramine hydrochloride - טבליות בשחרור איטי - clomipramine hydrochloride 75 mg - clomipramine - clomipramine - treatment of depressive states. obsessive compulsive disorders.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - cytarabine - אבקה להכנת תמיסה לזריקה - cytarabine 1 g/vial - cytarabine - cytarabine - induction and maintenance of remission in acute myelocytic leukemia of adults and children. treatment of other leukemias.

ישראל - עברית - Ministry of Health

novartis israel ltd - cytarabine - תמיסה להזרקה\אינפוזיה - cytarabine 50 mg / 1 ml - cytarabine - cytarabine - for induction and maintenance of clinical remission in patients with acute myeloid leukemia, acute non-lymphoblastic leukemias, acute lymphoblastic leukemias, blast crises of chronic myeloid leukemia, diffuse histiocytic lymphomas ( non-hodgkin's lymphomas of high malignancy).